Cargando…

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy

We dissected the T cell activation potency and the immunoglobulin (Ig) E-binding properties (allergenicity) of nine isoforms of Bet v 1 (Bet v 1a-Bet v 1l), the major birch pollen allergen. Immunoblot experiments showed that Bet v 1 isoforms differ in their ability to bind IgE from birch pollen-alle...

Descripción completa

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1996
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192443/ https://www.ncbi.nlm.nih.gov/pubmed/8627171

Ejemplares similares

NMR resonance assignments of a hypoallergenic isoform of the major birch pollen allergen Bet v 1
por: Ahammer, Linda, et al.
Publicado: (2017)

Ligand Recognition of the Major Birch Pollen Allergen Bet v 1 is Isoform Dependent
por: Seutter von Loetzen, Christian, et al.
Publicado: (2015)

Seven different genes encode a diverse mixture of isoforms of Bet v 1, the major birch pollen allergen
por: Schenk, Martijn F, et al.
Publicado: (2006)

Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial
por: Klimek, Ludger, et al.
Publicado: (2015)

Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms
por: Campana, Raffaela, et al.
Publicado: (2018)

The History and Science of the Major Birch Pollen Allergen Bet v 1
por: Breiteneder, Heimo, et al.
Publicado: (2023)

Crystallographically Mapped Ligand Binding Differs in High and Low IgE Binding Isoforms of Birch Pollen Allergen Bet v 1
por: Kofler, Stefan, et al.
Publicado: (2012)

Dynamics Rationalize Proteolytic Susceptibility of the Major Birch Pollen Allergen Bet v 1
por: Kamenik, Anna S., et al.
Publicado: (2020)

The Major Birch Pollen Allergen Bet v 1 Induces Different Responses in Dendritic Cells of Birch Pollen Allergic and Healthy Individuals
por: Smole, Ursula, et al.
Publicado: (2015)

Prophylactic and Therapeutic Effects of Oral Immunotherapy on Birch Pollen-Induced Allergic Conjunctivitis in Mice with a Rice-Based Edible Vaccine Expressing a Hypoallergenic Birch Pollen Allergen
por: Ishida, Waka, et al.
Publicado: (2021)

High-Yield Production of the Major Birch Pollen Allergen Bet v 1 With Allergen Immunogenicity in Nicotiana benthamiana
por: Yamada, Yuki, et al.
Publicado: (2020)

The Impact of Nitration on the Structure and Immunogenicity of the Major Birch Pollen Allergen Bet v 1.0101
por: Ackaert, Chloé, et al.
Publicado: (2014)

Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

Immunoglobulin E and G4 epitopes of the major allergen of birch pollen Bet v 1 share residues critical for antibody binding
por: Groh, N, et al.
Publicado: (2013)

Characterization of PR-10 genes from eight Betula species and detection of Bet v 1 isoforms in birch pollen
por: Schenk, Martijn F, et al.
Publicado: (2009)

Binding to Iron Quercetin Complexes Increases the Antioxidant Capacity of the Major Birch Pollen Allergen Bet v 1 and Reduces Its Allergenicity
por: Regner, Andreas, et al.
Publicado: (2022)

Retinoic acid‐loading of the major birch pollen allergen Bet v 1 may improve specific allergen immunotherapy: In silico, in vitro and in vivo data in BALB/c mice
por: Hufnagl, Karin, et al.
Publicado: (2020)

Stabilization of the Dimeric Birch Pollen Allergen Bet v 1 Impacts Its Immunological Properties
por: Kofler, Stefan, et al.
Publicado: (2014)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014)

Trimolecular complex between major birch pollen allergen, Bet v 1, monoclonal allergen-specific human IgE and recombinant CD23
por: Selb, Regina, et al.
Publicado: (2014)

Pru du 1, the Bet v 1‐homologue from almond, is a major allergen in patients with birch pollen associated almond allergy
por: Kabasser, Stefan, et al.
Publicado: (2022)

Ligand Binding Modulates the Structural Dynamics and Compactness of the Major Birch Pollen Allergen
por: Grutsch, Sarina, et al.
Publicado: (2014)

Identification of apple cultivars hypoallergenic for birch pollen‐allergic individuals by a multidisciplinary in vitro and in vivo approach
por: Strobl, Maria R., et al.
Publicado: (2022)

Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma
por: Wahn, Ulrich, et al.
Publicado: (2018)

Nitration of the Birch Pollen Allergen Bet v 1.0101: Efficiency and Site-Selectivity of Liquid and Gaseous Nitrating Agents
por: Reinmuth-Selzle, Kathrin, et al.
Publicado: (2014)

95 Specific Recognition of the Major Birch Pollen Allergen BET V 1 Programs Dendritic Cells to Induce Either th2 or Tolerogenic Responses
por: Smole, Ursula, et al.
Publicado: (2012)

Bet v 1 from Birch Pollen Is a Lipocalin-like Protein Acting as Allergen Only When Devoid of Iron by Promoting Th2 Lymphocytes
por: Roth-Walter, Franziska, et al.
Publicado: (2014)

Fold stability during endolysosomal acidification is a key factor for allergenicity and immunogenicity of the major birch pollen allergen
por: Machado, Yoan, et al.
Publicado: (2016)

Random mutagenesis and phage display technology as a tool for identifying ige epitopes of the birch pollen allergen Bet v 1
por: Guhsl, Elisabeth Eva, et al.
Publicado: (2014)

Chinese Birch Pollen Allergy and Immunotherapy in Mice
por: Xie, Zhijuan, et al.
Publicado: (2019)

Allergen‐specific immunotherapy with apples: selected cultivars could be a promising tool for birch pollen allergy
por: Nothegger, B., et al.
Publicado: (2020)

High Environmental Ozone Levels Lead to Enhanced Allergenicity of Birch Pollen
por: Beck, Isabelle, et al.
Publicado: (2013)

Comparative proteomics of common allergenic tree pollens of birch, alder, and hazel
por: Darnhofer, Barbara, et al.
Publicado: (2021)

Separation and characterization of nitrated variants of the major birch pollen allergen by CZE-ESI-μTOF MS
por: Gusenkov, Sergey, et al.
Publicado: (2013)

Top‐down and bottom‐up characterization of nitrated birch pollen allergen Bet v 1a with CZE hyphenated to an Orbitrap mass spectrometer
por: Gusenkov, Sergey, et al.
Publicado: (2018)

Filling the Antibody Pipeline in Allergy: PIPE Cloning of IgE, IgG(1) and IgG(4) against the Major Birch Pollen Allergen Bet v 1
por: Köhler, Verena K., et al.
Publicado: (2020)

Development of hypoallergenic variants of the major horse allergen Equ c 1 for immunotherapy by rational structure based engineering
por: Haka, Jaana, et al.
Publicado: (2019)

Do hypoallergenic cats exist? -- Determination of major cat allergen Fel d 1 production in normal and hypoallergenic cat breeds
por: Satorina, Julia, et al.
Publicado: (2014)

Evaluation of subcutaneous immunotherapy with birch pollen extract for pollen-food allergy syndrome
por: Hamada, Masaaki, et al.
Publicado: (2021)

Glutathione-S-Transferase: A Minor Allergen in Birch Pollen due to Limited Release from Hydrated Pollen
por: Deifl, Stephan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5o28dn4nf96bnnihmlddave48k